Skip to main content
TipRanks
Go Ultimate75% OFF

Adimmune Corporation (4142) Q2 2026 Earnings Report

TW:4142 Q2 2026 EPS Results

Actual EPS
-TWD 0.38
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-TWD 0.52

TW:4142 Q2 2026 Revenue Results

Actual Revenue
TWD 66.76M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-38.54%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/05/2026
Time
TBA
Conference Call
Wednesday, August 5, 2026
TW:4142 Upcoming Earnings

Adimmune Corporation's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

TW:4142 Earnings History

TW:4142 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 18, 20262026 (Q3)-0.040.47-0.041193.02% (+0.51)―
Aug 05, 20262026 (Q2)―-0.38-0.5226.78% (+0.14)
May 13, 20262026 (Q1)―-0.44-0.5316.98% (+0.09)
Mar 11, 20262025 (Q4)―0.52-0.12554.78% (+0.64)
Nov 12, 20252025 (Q3)―-0.040.61-107.05% (-0.65)
Aug 08, 20252025 (Q2)―-0.52-0.6520.15% (+0.13)
May 13, 20252025 (Q1)-0.65-0.53-0.44-21.56% (-0.09)
Mar 12, 20252024 (Q4)0.21-0.12-0.9888.29% (+0.87)
Nov 14, 20242024 (Q3)―0.610.63-2.56% (-0.02)
Aug 14, 20242024 (Q2)―-0.65-0.57-13.84% (-0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed